Salmol Syrup

Salmol Syrup

salbutamol

Manufacturer:

Biolab

Distributor:

Biopharm
Concise Prescribing Info
Contents
Salbutamol
Indications/Uses
Long-term treatment of asthma. Symptomatic management of bronchospasm in patients w/ reversible, obstructive airway disease eg, asthma, COPD & chronic bronchitis-associated bronchospasm.
Dosage/Direction for Use
Adult & childn >14 yr 5-10 mL tid-qid. Childn >6-14 yr 5 mL tid-qid, 2-6 yr Initially 0.4 mg/kg tid. Childn weighing 10-20 kg 2.5-5 mL tid. Elderly & β-adrenergic stimulator sensitive patients 5 mL tid-qid.
Administration
Should be taken on an empty stomach: Take 1 hr before or 2 hr after meals.
Contraindications
Hypersensitivity to salbutamol or adrenergic amines.
Special Precautions
CV disease (arrhythmia, HTN or heart failure), convulsive disorders, diabetes, glaucoma, hyperthyroidism or hypokalemia. May cause elevated BP & heart rate, CNS stimulation/excitation; increased risk of arrhythmia, increased serum glucose, decreased serum K. Pregnancy & lactation.
Adverse Reactions
Angina, atrial fibrillation, arrhythmias, chest discomfort & pain, extrasystoles, flushing, hyper-/hypotension, palpitation, supraventricular tachycardia, tachycardia; CNS stimulation, dizziness, drowsiness, headache, insomnia, irritability, lightheadedness, migraine, nervousness, nightmares, restlessness, seizure; angioedema, rash, urticaria; hyperglycemia, hypokalemia, lactic acidosis; diarrhea, dry mouth, dyspepsia, gastroenteritis, nausea, unusual taste, vomiting; micturition difficulty; muscle cramps, musculoskeletal pain, tremor, weakness; otitis media, vertigo; asthma exacerbation, bronchospasm, cough, epistaxis, laryngitis, oropharyngeal drying/irritation & edema, pharyngitis, rhinitis, upper resp inflammation, viral resp infection; allergic reaction, anaphylaxis, diaphoresis, lymphadenopathy.
Drug Interactions
Inhibited bronchodilating effects w/ β-blockers. Increased pressor response w/ methyldopa. Potentiated β-adrenergic agonist actions w/ MAOIs. Potentiated pressor response w/ TCAs. Decreased theophylline levels. Worsened ECG changes & hypokalemia w/ diuretics. Decreased serum digoxin conc.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03CC02 - salbutamol ; Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
Presentation/Packing
Form
Salmol Syrup 2 mg/5 mL
Packing/Price
60 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in